Reduce anxiety and improve functioning
- Trial ID
- NCT07310147
- Official Title
- Empower Your Mind to Embrace Your Life: Development and Efficacy Study of a Videoconference-delivered Group Intervention Based on Acceptance and Commitment Therapy for People With Young-onset Parkinson's Disease
- Goal
- Reduce anxiety and improve functioning
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Coimbra
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Empower your mind to embrace your life
Summary For Families
Aiming to help people with young-onset Parkinson's manage distress, anxiety, and loss of everyday functioning by increasing psychological flexibility and overall quality of life. It offers a group Acceptance and Commitment Therapy program delivered by videoconference, teaching acceptance of difficult thoughts and sensations, mindfulness, and committed, values-driven action; as a talk-based therapy it complements usual Parkinson's medications like levodopa and does not change how those drugs work. Looking for Portuguese-speaking adults 21 to 65 years old with neurologist-confirmed young-onset PD in Hoehn and Yahr stages 1 to 2.5, and excludes those currently in psychological treatment, pregnant people, anyone with current suicidal ideation, severe psychiatric illness, or cognitive impairment.
Locations
- CINEICC, Coimbra, Portugal
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Empower your mind to embrace your life. Aiming to help people with young-onset Parkinson's manage distress, anxiety, and loss of everyday functioning by increasing psychological flexibility and overall quality of life. It offers a group Acceptance and Commitment Therapy program delivered by videoconference, teaching acceptance of difficult thoughts and sensations, mindfulness, and committed, values-driven action; as a talk-based therapy it complements usual Parkinson's medications like levodopa and does not change how those drugs work. Looking for Portuguese-speaking adults 21 to 65 years old with neurologist-confirmed young-onset PD in Hoehn and Yahr stages 1 to 2.5, and excludes those currently in psychological treatment, pregnant people, anyone with current suicidal ideation, severe psychiatric illness, or cognitive impairment.
- Who can participate?
- Participants must be between 21 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.